Concepedia

Comparison of docetaxel/cisplatin to docetaxel/gemcitabine as first-line treatment of advanced non-small cell lung cancer: early results of a randomized trial

Vassilis Georgoulias, George Samonis, E. Papadakis, Athanasios Alexopoulos, Xanthi Tsiafaki, Aggeliki Rapti, M. Veslemes, T. Grigoratou, Ph. Palamidas, Ch. Kouroussis,

Lung Cancer · 2001 · 37 citations · 8 references

DOI

Concepts

References

8

Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study.

Heather Anderson, Birthe Lund, Flemming W. Bach et al. · Journal of Clinical Oncology · 1994 · 376 citations

, , +15

Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study.

Raymond P. Abratt, W. R. Bezwoda, Geoffrey Falkson et al. · Journal of Clinical Oncology · 1994 · 361 citations

, , +17

Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer.

Frank V. Fossella, J S Lee, William K. Murphy et al. · Journal of Clinical Oncology · 1994 · 223 citations

, , +16

Paclitaxel by 1-hour infusion: an active drug in metastatic non-small-cell lung cancer.

John D. Hainsworth, Dana S. Thompson, Filippo Greco · Journal of Clinical Oncology · 1995 · 159 citations

, , +10

Front-Line Treatment of Advanced Non–Small-Cell Lung Cancer With Docetaxel and Gemcitabine: A Multicenter Phase II Trial

Vassilis Georgoulias, Charalambos Kouroussis, N. Androulakis et al. · Journal of Clinical Oncology · 1999 · 128 citations

, , +15